13
false
false
false
false
false
false
false
false
false
false
true
false
false
false
false
false
false
No description of principal activity
2023-10-01
Sage Accounts Production Advanced 2023 - FRS102_2023
44,052
10,603
14,160
40,495
26,130
4,700
9,983
20,847
19,648
17,922
xbrli:pure
xbrli:shares
iso4217:GBP
06227254
2023-10-01
2024-06-30
06227254
2024-06-30
06227254
2023-09-30
06227254
2022-10-01
2023-09-30
06227254
2023-09-30
06227254
2022-09-30
06227254
core:FurnitureFittings
2023-10-01
2024-06-30
06227254
bus:Director4
2023-10-01
2024-06-30
06227254
bus:Director1
2023-10-01
2024-06-30
06227254
bus:Director2
2023-10-01
2024-06-30
06227254
core:FurnitureFittings
2023-09-30
06227254
core:FurnitureFittings
2024-06-30
06227254
core:WithinOneYear
2024-06-30
06227254
core:WithinOneYear
2023-09-30
06227254
core:AfterOneYear
2024-06-30
06227254
core:AfterOneYear
2023-09-30
06227254
core:ShareCapital
2024-06-30
06227254
core:ShareCapital
2023-09-30
06227254
core:OtherReservesSubtotal
2024-06-30
06227254
core:OtherReservesSubtotal
2023-09-30
06227254
core:RetainedEarningsAccumulatedLosses
2024-06-30
06227254
core:RetainedEarningsAccumulatedLosses
2023-09-30
06227254
core:FurnitureFittings
2023-09-30
06227254
bus:Director1
2023-09-30
06227254
bus:Director1
2024-06-30
06227254
bus:Director2
2023-09-30
06227254
bus:Director2
2024-06-30
06227254
bus:Director1
2022-09-30
06227254
bus:Director1
2023-09-30
06227254
bus:Director2
2022-09-30
06227254
bus:Director2
2023-09-30
06227254
bus:Director1
2022-10-01
2023-09-30
06227254
bus:Director2
2022-10-01
2023-09-30
06227254
bus:SmallEntities
2023-10-01
2024-06-30
06227254
bus:AuditExempt-NoAccountantsReport
2023-10-01
2024-06-30
06227254
bus:SmallCompaniesRegimeForAccounts
2023-10-01
2024-06-30
06227254
bus:PrivateLimitedCompanyLtd
2023-10-01
2024-06-30
06227254
bus:FullAccounts
2023-10-01
2024-06-30
06227254
core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl
2023-10-01
2024-06-30
COMPANY REGISTRATION NUMBER:
06227254
Kinesys Consulting Limited |
|
Filleted Unaudited Financial Statements |
|
Kinesys Consulting Limited |
|
Statement of Financial Position |
|
30 June 2024
|
30 Jun 24 |
30 Sep 23 |
Note |
£ |
£ |
£ |
|
|
|
|
Fixed assets
Tangible assets |
6 |
|
19,648 |
17,922 |
|
|
|
|
|
Current assets
Debtors |
7 |
300,653 |
|
347,986 |
Cash at bank and in hand |
428,874 |
|
147,186 |
|
--------- |
|
--------- |
|
729,527 |
|
495,172 |
|
|
|
|
|
Creditors: amounts falling due within one year |
8 |
(
265,152) |
|
(
283,180) |
|
--------- |
|
--------- |
Net current assets |
|
464,375 |
211,992 |
|
|
--------- |
--------- |
Total assets less current liabilities |
|
484,023 |
229,914 |
|
|
|
|
|
Creditors: amounts falling due after more than one year |
9 |
|
(
7,936) |
(
13,333) |
|
|
|
|
|
Provisions
Taxation including deferred tax |
|
596 |
18,171 |
|
|
--------- |
--------- |
Net assets |
|
476,683 |
234,752 |
|
|
--------- |
--------- |
|
|
|
|
Capital and reserves
Called up share capital |
|
200 |
200 |
Share Option reserve |
|
2,384 |
72,683 |
Profit and loss account |
|
474,099 |
161,869 |
|
|
--------- |
--------- |
Shareholders funds |
|
476,683 |
234,752 |
|
|
--------- |
--------- |
|
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476
;
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements
.
Kinesys Consulting Limited |
|
Statement of Financial Position (continued) |
|
30 June 2024
These financial statements were approved by the
board of directors
and authorised for issue on
10 March 2025
, and are signed on behalf of the board by:
Company registration number:
06227254
Kinesys Consulting Limited |
|
Notes to the Financial Statements |
|
Period from 1 October 2023 to 30 June 2024
1.
General information
The company is a private company limited by shares, registered in England. The address of the registered office is Pitcairn House, Crown Square, First Avenue, Centrum 100, Burton-on-Trent, Staffordshire, DE14 2WW.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The accounting reference date was shortened from 30 September 2024 to 30 June 2024, the current financial reference period being 9-months. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for services rendered, net of discounts and Value Added Tax. Revenue from the sale of services is recognised when the service is delivered and recognised in the period in which the services are provided on completion of set performance obligations; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
|
Fixtures & fittings |
- |
25% reducing balance |
|
|
|
|
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Share-based payments
Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value is expensed on a straight-line basis over the vesting period, with a corresponding increase in equity. This is based upon the company's estimate of the shares or share options that will eventually vest which takes into account all vesting conditions and non-market performance conditions, with adjustments being made where new information indicates the number of shares or share options expected to vest differs from previous estimates. Fair value is determined using an appropriate pricing model. All market conditions and non-vesting conditions are taken into account when estimating the fair value of the shares or share options. As long as all other vesting conditions are satisfied, no adjustment is made irrespective of whether market or non-vesting conditions are met. Where the terms of an equity-settled transaction are modified, an expense is recognised as if the terms had not been modified. In addition, an expense is recognised for any increase in the fair value of the transaction, as measured at the date of modification. Where an equity-settled transaction is cancelled or settled, it is treated as if it had vested on the date of cancellation or settlement, and any expense not yet recognised in profit or loss is expensed immediately. Cash-settled share-based payment transactions are measured at the fair value of the liability. Until the liability is settled, the fair value of the liability is re-measured at each reporting date and at the date of settlement, with any changes in fair value recognised in profit or loss for the period.
4.
Staff costs
The average number of persons employed by the company during the period amounted to
13
(2023:
13
).
The aggregate employment costs incurred during the period were:
|
Period from |
|
|
1 Oct 23 to |
Year to |
|
30 Jun 24 |
30 Sep 23 |
|
£ |
£ |
Wages and salaries |
464,478 |
715,743 |
Social security costs |
54,440 |
66,103 |
Other pension costs |
9,620 |
12,039 |
|
--------- |
--------- |
|
528,538 |
793,885 |
|
--------- |
--------- |
|
|
|
5.
Enterprise management incentives - share scheme
Certain employees participate in an EMI Share Scheme, which provides additional remuneration for those employees who are key to the operations of the company. Vesting of the options is subject to continued employment within the company. The company recognises a liability at the balance sheet date based on the fair value, taking into account the estimated number of options that will actually vest and the current proportion of the vesting period that has lapsed. Changes in the value of this liability are recognised in the income statement.
The options granted total 7,360 (2023: 2,492) and the total charge for the year was £2,384 (2023: £72,683), included in Wages and salaries costs above.
6.
Tangible assets
|
Fixtures and fittings |
Total |
|
£ |
£ |
Cost |
|
|
At 1 October 2023 |
44,052 |
44,052 |
Additions |
10,603 |
10,603 |
Disposals |
(
14,160) |
(
14,160) |
|
-------- |
-------- |
At 30 June 2024 |
40,495 |
40,495 |
|
-------- |
-------- |
Depreciation |
|
|
At 1 October 2023 |
26,130 |
26,130 |
Charge for the period |
4,700 |
4,700 |
Disposals |
(
9,983) |
(
9,983) |
|
-------- |
-------- |
At 30 June 2024 |
20,847 |
20,847 |
|
-------- |
-------- |
Carrying amount |
|
|
At 30 June 2024 |
19,648 |
19,648 |
|
-------- |
-------- |
At 30 September 2023 |
17,922 |
17,922 |
|
-------- |
-------- |
|
|
|
7.
Debtors
|
30 Jun 24 |
30 Sep 23 |
|
£ |
£ |
Trade debtors |
291,580 |
343,599 |
Other debtors |
9,073 |
4,387 |
|
--------- |
--------- |
|
300,653 |
347,986 |
|
--------- |
--------- |
|
|
|
8.
Creditors:
amounts falling due within one year
|
30 Jun 24 |
30 Sep 23 |
|
£ |
£ |
Bank loans and overdrafts |
27,333 |
22,781 |
Trade creditors |
27,382 |
13,123 |
Corporation tax |
146,180 |
135,434 |
Social security and other taxes |
41,694 |
49,575 |
Pension creditor |
3,364 |
13,279 |
Other creditors |
19,199 |
48,988 |
|
--------- |
--------- |
|
265,152 |
283,180 |
|
--------- |
--------- |
|
|
|
9.
Creditors:
amounts falling due after more than one year
|
30 Jun 24 |
30 Sep 23 |
|
£ |
£ |
Bank loans and overdrafts |
7,936 |
13,333 |
|
------- |
-------- |
|
|
|
10.
Post balance sheet events
On 01 August 2024, the company was sold to Clinigen Healthcare Limited and Mr McGettigan and Mrs Murphy resigned as directors. On 30 November 2024 the trade and assets of the company were transferred to its immediate parent undertaking, Clinigen Healthcare Limited.
11.
Directors' advances, credits and guarantees
During the period the directors entered into the following advances and credits with the company:
|
30 Jun 24 |
|
|
Balance brought forward |
Advances/ (credits) to the directors |
Balance outstanding |
|
|
£ |
£ |
£ |
|
G McGettigan |
(
102) |
125 |
23 |
|
E Murphy |
(
102) |
125 |
23 |
|
|
---- |
---- |
---- |
|
|
(
204) |
250 |
46 |
|
|
---- |
---- |
---- |
|
|
|
|
|
|
30 Sep 23 |
|
|
Balance brought forward |
Advances/ (credits) to the directors |
Balance outstanding |
|
|
£ |
£ |
£ |
|
G McGettigan |
5,055 |
(
5,157) |
(
102) |
|
E Murphy |
5,056 |
(
5,158) |
(
102) |
|
|
-------- |
-------- |
---- |
|
|
10,111 |
(
10,315) |
(
204) |
|
|
-------- |
-------- |
---- |
|
|
|
|
|
12.
Related party transactions
The company was under the control of
G McGettigan
and E Murphy
throughout the current period and previous year. Mr McGettigan and Mrs Murphy were directors and shareholders.
13.
Controlling party
The Company is a wholly owned subsidiary undertaking of Clinigen Healthcare Limited. The ultimate parent undertaking is Triton Fund V which is managed and controlled by its general partners Triton Managers V Limited, TFF V Limited and Triton Fund V GP S.a.r.l. The ultimate controlling party is considered to be the directors of Triton Managers V Limited and TFF V Limited. Triley Midco Limited, a company incorporated and registered in the United Kingdom, is the parent of the smallest and largest group of undertakings to consolidate these financial statements. The consolidated accounts of Triley Midco Limited are lodged at UK Companies House.